Biodegradable Glaucoma Drainage Sheet With Gradient Scar Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional glaucoma drainage apparatuses face issues such as rapid aqueous humor drainage leading to complications, encapsulation by scar tissues causing IOP increase, and corneal endothelial cell loss due to foreign body stimulation, with current anti-scarring drugs having short-lived effects and toxicity concerns.
Innovation Solution
A biodegradable drainage sheet with a non-monotonic anti-scarring drug distribution in a surface coating, gradually releasing drugs to control scar formation and maintain effective drainage, using magnesium alloys for strength and biocompatibility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional fixed-diameter drainage tube is used, then drainage function is provided, but rapid drainage causes shallow anterior chamber and corneal endothelial cell loss
Solution Approach 1:
The drainage tube diameter dynamically changes over time through biodegradation. The tube starts with a larger diameter for effective drainage, then gradually reduces as the biodegradable material degrades, automatically adapting to the healing process and preventing complications from excessive drainage
Solution Approach 2:
The physical parameter of tube diameter changes over time through material degradation. The biodegradable polymer progressively breaks down, causing the tube diameter to decrease from an initial larger size to a smaller size, matching the physiological needs during different healing stages
2Duration of action of stationary object
If traditional drainage apparatus is used long-term, then drainage is maintained, but scar tissue encapsulation reduces drainage volume and increases IOP
Solution Approach 1:
The drainage tube is designed as a temporary, short-term implant that performs its drainage function during the critical early healing period, then biodegrades and is naturally eliminated by the body. This temporary presence minimizes long-term foreign body reaction and scar encapsulation while providing necessary drainage support when most needed
Solution Approach 2:
The biodegradable tube gradually breaks down and is discarded by the body's natural metabolic processes. As the tube degrades, it is recovered by cellular mechanisms that process the biodegradable polymer, eliminating the need for removal surgery and reducing chronic foreign body stimulation that causes scarring
3Object-affected harmful factors
If anti-scarring drugs are applied under conjunctiva, then scar formation is reduced temporarily, but drug effect is short-lived and requires high concentration with toxicity
Solution Approach 1:
The anti-scarring drug is pre-loaded into the drainage tube structure during manufacturing. As the tube degrades over time, the drug is gradually released in a sustained manner, providing prolonged anti-scarring protection without requiring high initial concentrations or repeated applications
Solution Approach 2:
The biodegradable drainage tube acts as an intermediary carrier that delivers the anti-scarring drug to the target site. The tube's gradual degradation controls the drug release rate, providing sustained low-dose delivery that reduces toxicity while maintaining effectiveness
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The apparatus ensures safe, unobstructed drainage, reduces IOP, minimizes corneal endothelial cell loss, and enhances surgical success by controlling scar formation and degradation, improving surgical efficiency and safety.
Implementation Method 1
The outer surface of the drainage sheet is coated with a biodegradable surface coating, and the surface coating carries an anti-scarring drug. The anti-scarring drug is configured to be gradually released as the surface coating degrades
Data Source
AI summary
Embodiments of the present disclosure provide a drainage apparatuses with scar gradient control capabilities for degradable glaucoma and methods of making the same cross-reference to related applications, comprising a long-strip-shaped drainage sheet with a uniform overall cross-sectional size, wherein the drainage sheet is made of a biodegradable material, an outer surface of the drainage sheet is provided with a drainage gap that penetrates through opposite sides of the drainage sheet, an outer surface of the drainage sheet is coated with a biodegradable surface coating, and the surface coating carries an anti-scarring drug, wherein the anti-scarring drug is configured to be gradually released as the surface coating degrades, and a distribution concentration of the anti-scarring drug within the surface coating varies in a non-monotonic manner.


